circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer

被引：0
|
作者：
Hailin Tang
Xiaojia Huang
Jin Wang
Lu Yang
Yanan Kong
Guanfeng Gao
Lijuan Zhang
Zhe-Sheng Chen
Xiaoming Xie
机构：
[1] Sun Yat-sen University Cancer Center,Department of Breast Oncology
[2] State Key Laboratory of Oncology in South China,Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences
[3] Collaborative Innovation Center of Cancer Medicine,undefined
[4] St. John’s University,undefined
[5] Queens,undefined
来源：
Molecular Cancer | / 18卷
关键词：
Circular RNAs; miR-375; KIF4A; Competitive endogenous RNAs; Triple negative breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor
    Sebastian Sebastian, C.
    Garcia Mur, C.
    Cruz Ciria, S.
    Rosero Cuesta, D. S.
    Gros Baneres, B.
    RADIOLOGIA, 2016, 58 (04): : 283 - 293
  • [32] Is triple negative a prognostic factor in breast cancer?
    Nishimura, R.
    Arima, N.
    Osako, T.
    Okumura, Y.
    EJC SUPPLEMENTS, 2008, 6 (07): : 87 - 87
  • [33] Is triple negative a prognostic factor in breast cancer?
    Nishimura, Reiki
    Arima, Nobuyuki
    BREAST CANCER, 2008, 15 (04) : 303 - 308
  • [34] Is triple negative a prognostic factor in breast cancer?
    Reiki Nishimura
    Nobuyuki Arima
    Breast Cancer, 2008, 15 : 303 - 308
  • [35] KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer
    Takuya Nagata
    Yutaka Shimada
    Shinichi Sekine
    Makoto Moriyama
    Isaya Hashimoto
    Koshi Matsui
    Tomoyuki Okumura
    Takashi Hori
    Johji Imura
    Kazuhiro Tsukada
    Breast Cancer, 2017, 24 : 326 - 335
  • [36] KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer
    Nagata, Takuya
    Shimada, Yutaka
    Sekine, Shinichi
    Moriyama, Makoto
    Hashimoto, Isaya
    Matsui, Koshi
    Okumura, Tomoyuki
    Hori, Takashi
    Imura, Johji
    Tsukada, Kazuhiro
    BREAST CANCER, 2017, 24 (02) : 326 - 335
  • [37] The Epidemiology, Clinico-Pathologic and Prognostic Characteristics of Triple-Negative Breast Cancer Compared with Non Triple-Negative Breast Cancer
    Kwong, A.
    Wong, K.
    Wong, C. H. N.
    Leung, C.
    CANCER RESEARCH, 2009, 69 (24) : 669S - 669S
  • [38] Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer
    Cheng, Chee Leong
    Thike, Aye Aye
    Tan, Sie Yong Jane
    Chua, Pei Jou
    Bay, Boon Huat
    Tan, Puay Hoon
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 99 - 111
  • [39] Interleukin 17A is a poor prognostic factor for triple-negative breast cancer patients
    Khalid, Freeha
    Takagi, Kiyoshi
    Miki, Yasuhiro
    Miyashita, Minoru
    Suzuki, Takashi
    Sasano, Hironobu
    CANCER SCIENCE, 2021, 112 : 254 - 254
  • [40] High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
    Zagouri, F.
    Bago-Horvath, Z.
    Roessler, F.
    Brandstetter, A.
    Bartsch, R.
    Papadimitriou, C. A.
    Dimitrakakis, C.
    Tsigginou, A.
    Papaspyrou, I.
    Giannos, A.
    Dimopoulos, M-A
    Filipits, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1100 - 1105
12345